AI assistant
Sending…
Korro Bio, Inc. — Director's Dealing 2023
Nov 8, 2023
33032_dirs_2023-11-07_9fc8089d-a7f6-497d-980b-cb6eb3f9d3b2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Korro Bio, Inc. (KRRO)
CIK: 0001703647
Period of Report: 2023-11-03
Reporting Person: Agarwal Vineet (N/A)
More from Korro Bio, Inc.
Regulatory Filings
2026
May 19
Regulatory Filings
2026
May 12
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 16
Proxy Solicitation & Information Statement
2026
Apr 16
Regulatory Filings
2026
Mar 23
Capital/Financing Update
2026
Mar 20
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17